Trupanion (NASDAQ:TRUP) Price Target Raised to $45.00

Key Points

• Investment analysts at Stifel Nicolaus raised Trupanion's price target to $45.00, indicating a potential downside of 10.67% from its previous close.
• Trupanion's stock recently saw a 3.3% increase in value, trading at $50.38 during Friday's sessions.
• The company reported quarterly earnings of $0.22 per share, outperforming consensus estimates and showing a 12.3% year-over-year revenue increase.

Trupanion (NASDAQ:TRUP - Get Free Report) had its target price boosted by Stifel Nicolaus from $41.00 to $45.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a "hold" rating on the financial services provider's stock. Stifel Nicolaus' target price would suggest a potential downside of 9.40% from the company's current price.

Several other research firms have also commented on TRUP. Lake Street Capital lowered their price objective on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. Piper Sandler set a $67.00 price target on Trupanion and gave the stock an "overweight" rating in a report on Friday. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $55.60.

Trupanion Stock Performance

TRUP traded up $0.18 on Friday, reaching $49.67. 33,525 shares of the stock were exchanged, compared to its average volume of 603,319. The company's 50-day moving average price is $51.16 and its 200 day moving average price is $43.98. Trupanion has a fifty-two week low of $31.00 and a fifty-two week high of $57.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a market capitalization of $2.14 billion, a PE ratio of 190.50 and a beta of 1.78.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%. The business had revenue of $353.56 million for the quarter, compared to analyst estimates of $346.73 million. During the same quarter in the prior year, the firm posted ($0.14) EPS. The business's quarterly revenue was up 12.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Trupanion will post 0.13 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 4,000 shares of the company's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total value of $183,440.00. Following the completion of the transaction, the chief executive officer owned 118,784 shares of the company's stock, valued at approximately $5,447,434.24. This represents a 3.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO John R. Gallagher sold 4,000 shares of the stock in a transaction that occurred on Thursday, May 29th. The shares were sold at an average price of $47.90, for a total value of $191,600.00. Following the transaction, the chief operating officer directly owned 26,966 shares of the company's stock, valued at $1,291,671.40. The trade was a 12.92% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,562 shares of company stock valued at $544,870. 5.42% of the stock is owned by company insiders.

Institutional Investors Weigh In On Trupanion

Large investors have recently made changes to their positions in the stock. Palisade Capital Management LP grew its position in shares of Trupanion by 36.7% in the first quarter. Palisade Capital Management LP now owns 244,354 shares of the financial services provider's stock valued at $9,107,000 after purchasing an additional 65,653 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Trupanion by 112.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock valued at $13,204,000 after purchasing an additional 144,828 shares in the last quarter. Northern Trust Corp grew its position in shares of Trupanion by 9.0% in the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock valued at $17,749,000 after purchasing an additional 30,549 shares in the last quarter. Balyasny Asset Management L.P. grew its position in Trupanion by 368.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after acquiring an additional 661,559 shares during the period. Finally, American Century Companies Inc. purchased a new position in Trupanion in the fourth quarter worth approximately $1,111,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.